Good Samaritan Medical Center Brings New Technology and Services to the Newly Redesigned Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches

Good Samaritan Medical Center part of the Palm Beach Health Network, has announced a new look and new equipment in the redesigned Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches.

The Palm Beach Health Network invested nearly a quarter of a million dollars into the center, bringing a sleek and calm aesthetic look, along with some of the newest high-end technology for patients being treated for their breast health.

“As we continue to change the way we treat breast cancer, it is important we continue to keep up with the latest and newest technology, so the residents of Palm Beach County can benefit from getting the very best treatments for their overall breast health,” said Sheri Montgomery, chief executive officer for Good Samaritan Medical Center. “As we have done for over 100 years, our newly redesigned center will continue to provide amazing quality care to the South Florida community.”

Some of the new additions to the center include:

  • The Genius 3D Mammography™ exam with Hologic Clarity HD – This technology generates images of the breast that are sharper and even more detailed so a cancer can be detected earlier, when it is easier to treat. It also cuts down on unnecessary follow-up appointments by up to 40% compared to 2D imaging alone. It also produces images quicker so less time for the patient to have their breast under compression
  • Affirm Breast Biopsy Guidance System – This system allows doctors to quickly perform 3D breast biopsies on patients and accurately target regions of interest for a breast biopsy assisting in breast cancer detection.
  • Supersonic Mach 40 Ultrasound – The Ultrasound system gives the highest resolution images of patients to enhance diagnostic certainty, regardless of tissue density.

“We feel confident that by offering these new technological capabilities it will ensure greater patient care and confidence for those who come in for their yearly mammograms,” said Dr. Elena Rehl, breast surgeon on staff at Good Samaritan Medical Center. “It is so important not to delay care, especially for your annual mammogram.  If you have been putting it off, we encourage you to make an appointment today.”

The Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches brings together a multi-disciplinary team of cancer specialists and allied health professionals, advanced technology and cancer resources so patients and their families may receive a comprehensive diagnosis, treatment and support services.  Call 561-650-6441 or visit www.goodsamaritanmc.com.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.